Association between IgG antibody levels and adverse events after first and second Bnt162b2 mRNA vaccine doses

OBJECTIVES: This study sought to correlate the SARS-CoV-2 IgG antibody response level to the BNT162b2 (Pfizer BioNTech) mRNA vaccine after the first and second doses with the reported adverse events. METHODS: This cohort study examined the adverse events profiles of people vaccinated with BNT162b2 i...

Descripción completa

Detalles Bibliográficos
Autores principales: Braun, Eyal, Horowitz, Netanel A., Leiba, Ronit, Weissman, Avi, Mekel, Michal, Shachor-Meyouhas, Yael, Hussein, Khetam, Halberthal, Michael, Azzam, Zaher S., Berger, Gidon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9283125/
https://www.ncbi.nlm.nih.gov/pubmed/35843565
http://dx.doi.org/10.1016/j.cmi.2022.07.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9283125/
https://www.ncbi.nlm.nih.gov/pubmed/35843565
http://dx.doi.org/10.1016/j.cmi.2022.07.002

Ejemplares similares